HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

4th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 19-21, 2023 | Boston, Massachusetts, USA

Exhibitor

AbbVie was founded in 2013 when we became a separate company from Abbott. Our name represents a proud connection to that legacy.

Since the beginning, our mission hasn't wavered. Our combination of focused innovation and commercial scale brings differentiated products to market that benefit patients, customers and health care providers.

At AbbVie, our R&D teams are chasing bold goals. The therapies and solutions that no one else has achieved or even attempted. And we want to be there first. That's what we go after every day for our patients.

Science and innovation are the lifeblood of our company. From drug discovery to clinical trials to regulatory approval, we're pursuing new ways to address patients' most challenging health issues.

Since our launch in 2013, we've invested more than $55 billion in R&D. This enables us to discover and deliver innovative medicines and products that solve serious health issues, enhance people's lives today, and address tomorrow's medical challenges.

We focus on core areas where our proven expertise and bold thinking have the greatest potential to solve unmet needs. These areas are oncology, immunology, neuroscience, eye care, medical aesthetics and other specialty areas.

Contact Information:
Name: Shraddha Samant Email: shraddha.samant@Abbvie.com
Phone Numbers: +1 847-937-3622
Website: https://www.abbvie.com/

Watsapp